Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis

被引:11
|
作者
Ma, Yushan [1 ,2 ]
Wang, Jierui [3 ]
Guo, Shuo [1 ]
Meng, Zirui [1 ]
Ren, Yan [1 ]
Xie, Yi [1 ]
Wang, Minjin [1 ,3 ]
机构
[1] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu, Peoples R China
[2] Third Hosp Mianyang, Sichuan Mental Hlth Ctr, Dept Lab Med, Mianyang, Peoples R China
[3] Sichuan Univ, Dept Neurol, West China Hosp, Chengdu, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 13卷
关键词
cytokine; chemokine; T cell; NMDAR encephalitis; meta-analysis; ASPARTATE RECEPTOR ENCEPHALITIS; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; APRIL LEVELS; DIAGNOSIS; CYTOKINE; BRAIN; BIOMARKER; DISEASE; CXCL13;
D O I
10.3389/fimmu.2022.1064007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives To summarize the cytokine/chemokine levels of anti-N-methyl-Daspartate receptor encephalitis (NMDAR-E) and explore the potential role of these molecules and immune cells in the pathogenic mechanism.Methods The PubMed, Cochrane Library, Embase, and Web of Science databases were searched for various articles that assessed the concentrations of cytokines/chemokines in the unstimulated cerebrospinal fluid (CSF) or serum of patients with NMDAR-E in this systematic review and meta-analysis. The standardized mean difference (SMD) and 95% confidence interval (CI) were calculated by Stata17.0.Results A total of 19 articles were included in the systematic review from 260 candidate papers, and cytokine/chemokine levels reported in the CSF/serum were examined in each article. This meta-analysis included 17 eligible studies comprising 579 patients with NMDAR-E, 367 patients with noninflammatory neurological disorders, and 42 healthy controls from China, Spain, South Korea, Australia, Czechia, and Sweden. The results indicated that the levels of different cytokines interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, IL-10, IL-13, IL-1 beta, IL-12, and IL-17 and chemokine C-X-C motif ligand (CXCL)10 in the CSF were significantly higher in NMDAR-E patients with a large effect size. In addition, B cell activating factor (BAFF), CXCL13, and interferon (IFN)-gamma levels in the CSF were higher in NMDAR-E patients with a middle effect size. In contrast, levels of IL-2 and IL-4 in the CSF and CXCL13 and BAFF in the serum did not show a significant difference between cases and controls.Conclusions These analyses showed that the central immune response in NMDAR-E is a process that involves multiple immune cell interactions mediated by cytokines/chemokines, and T cells play an important role in the pathogenesis of immunity.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier (CRD42022342485).
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis
    Ding, Jiayue
    Li, Xiangyu
    Tian, Zhiyan
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [2] Evaluation of serum cytokine and chemokine levels in dermatitis herpetiformis: a systematic review and meta-analysis
    Kowalski, E. H.
    Kneibner, D.
    Patel, A.
    Kridin, K.
    Amber, K. T.
    IMMUNOLOGIC RESEARCH, 2019, 67 (2-3) : 265 - 266
  • [3] Evaluation of serum cytokine and chemokine levels in dermatitis herpetiformis: a systematic review and meta-analysis
    EH. Kowalski
    D. Kneibner
    A Patel
    K Kridin
    KT. Amber
    Immunologic Research, 2019, 67 : 265 - 266
  • [4] Plasma exchange in pediatric anti-NMDAR encephalitis: A systematic review
    Suppiej, Agnese
    Nosadini, Margherita
    Zuliani, Luigi
    Pelizza, Maria Federica
    Toldo, Irene
    Bertossi, Chiara
    Tison, Tiziana
    Zoccarato, Marco
    Marson, Piero
    Giometto, Bruno
    Dale, Russell C.
    Sartori, Stefano
    BRAIN & DEVELOPMENT, 2016, 38 (07): : 613 - 622
  • [5] Anti-NMDAR encephalitis preceded by infection: Systematic literature review with comparison of non-HSV and HSV related anti-NMDAR encephalitis
    Kumar, Panda Ashwin
    Chowdhury, Debashish
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 29 - 29
  • [6] Analysis of relapses in anti-NMDAR encephalitis
    Gabilondo, I.
    Saiz, A.
    Galan, L.
    Gonzalez, V.
    Jadraque, R.
    Sabater, L.
    Sans, A.
    Sempere, A.
    Vela, A.
    Villalobos, F.
    Vinals, M.
    Villoslada, P.
    Graus, F.
    NEUROLOGY, 2011, 77 (10) : 996 - 999
  • [7] CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis
    Desestret, Virginie
    Chefdeville, Aude
    Viaccoz, Aurelien
    Bost, Chloe
    Ducray, Francois
    Picard, Geraldine
    Rogemond, Veronique
    Chaffois, Marie-Oceane
    Blanc, Charlotte
    Bardel, Claire
    Treilleux, Isabelle
    Pascual, Olivier
    Antoine, Jean-Christophe
    Delattre, Jean-Yves
    Honnorat, Jerome
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2015, 2 (06):
  • [8] Fetal outcome in anti-NMDAR encephalitis during pregnancy: A systematic review
    Scorrano, Giovanna
    Dono, Fedele
    Evangelista, Giacomo
    Consoli, Stefano
    Bonanni, Laura
    Onofrj, Marco
    Chiarelli, Francesco
    Anzellotti, Francesca
    EPILEPSIA, 2021, 62 : 310 - 310
  • [9] Blood and CSF findings of cellular immunity in anti-NMDAR encephalitis
    Wang, Jierui
    Luo, Limei
    Meng, Zirui
    Ren, Yan
    Tang, Meng
    Huang, Zhuochun
    Yang, Bin
    Niu, Qian
    Zhou, Dong
    Wang, Minjin
    Li, Jinmei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130
  • [10] Absence of serum anti-NMDAR antibodies in anti-NMDAR encephalitis mother predicts having healthy newborn
    Ueda, Akihiro
    Nagao, Ryunosuke
    Maeda, Toshiki
    Kikuchi, Kouichi
    Murate, Kenichiro
    Niimi, Yoshiki
    Shima, Sayuri
    Mutoh, Tatsuro
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 161 : 14 - 16